|
|
|
| Experience of traditional Chinese medicine master Professor Wang Lie in treating recurrent respiratory tract infections in children |
| ZHU Jinpu1 WANG Lie2 SUN Liping2 |
1.College of Chinese Medicine, Changchun University of Chinese Medicine, Jilin Province, Changchun 130117, China;
2.Center of Children’s Clinic, the Affiliated Hospital to Changchun University of Chinese Medicine, Jilin Province, Changchun 130022, China |
|
|
|
Abstract This paper summarizes the clinical experience of Professor Wang Lie, a traditional Chinese medicine master, in treating recurrent respiratory tract infections in children. According to the pathogenesis and morbidity characteristics, Professor Wang divides the disease into three phases: the acute infection phase, the non-acute infection phase and the consolidation treatment phase. Professor Wang believes that during the acute infection phase, the intertwining of external evils and internal toxins is the main pathogenesis that leads to persistent fever. The treatment should clearly distinguish between the excess and the deficiency. The patient who is suffering from excess should be given the modified Qinggan Decoction which could clear sense and toxic materials. For the patient who is suffering from deficiency, medicines that clear deficiency heat and nourish yin should be used. During the non-acute infection phase, the lung, spleen and kidney are mainly to be regulated, and the treatment relies on the syndrome differentiation and the identification of deficiencies and excesses. For the patient with food accumulation and lung heat, Professor Wang matches Scutellariae Radix and other herbs to transport the spleen. In this way, the lung heat could be cleared and accumulation and stagnation could be eliminated. If there is deficiency in the lung, spleen, and kidney, Professor Wang uses modified Yiqi Qiangshen Decoction to benefit qi and strengthen the vital qi. In the case of lung yin in deficiency syndrome, Professor Wang uses modified Bufei Decoction to moisten the lung and nourish yin. During the consolidation treatment phase, great attention should be paid to the prevent recurrence of disease after treatment, and therefore Professor Wang adopts combined internal external therapy. In this situation, the Pediatric Longmu Capsules and Yiqi Guben Capsules are commonly used in combination with the Fangfu Sachet. Scientific maintenance methods and a balanced diet are advocated as well. The clinical results are significant, and one medical record is attached to prove our view.
|
|
|
|
|
|
[1] 王力宁，汪受传，韩新民，等.小儿反复呼吸道感染中医诊疗指南[J].中医儿科杂志，2008，4（6）：3-4.
[2] 孙金峤，农光民，曹玲，等.儿童反复呼吸道感染临床诊疗路径（2022版）[J].中国实用儿科杂志，2022，37（3）：161- 168.
[3] Schaad UB，Esposito S，Razi CH. Diagnosis and management of recurrent respiratory tract infections in children：a practical guide [J]. Arch Pediatr Infect Dis，2016，4（1）：e31039.
[4] 《中成药治疗优势病种临床应用指南》标准化项目组.中成药治疗小儿反复呼吸道感染临床应用指南（2021年）[J].中国中西医结合杂志，2022，42（2）：133-142.
[5] Zhou B，Niu W，Liu F，et al. Risk factors for recurrent respiratory tract infection in preschool-aged children [J]. Pediatr Res，2021，90（1）：223-231.
[6] Karevold G，Kvestad E，Nafstad P，et al. Respiratory infections in schoolchildren：co-morbidity and risk factors [J]. Arch Dis Child，2006，91（5）：391-395.
[7] de Benedictis FM，Bush A. Recurrent lower respiratory tract infections in children [J]. BMJ，2018，362：k2698.
[8] Toivonen L，Karppinen S，Schuez-Havupalo L，et al. Burden of recurrent respiratory tract infections in children [J]. Pediatr Infect Dis J，2016，35（12）：e362-e369.
[9] Vallianou N，Dalamaga M，Stratigou T，et al. Do antibiotics cause obesity through long-term alterations in the gut microbiome? A review of current evidence [J]. Curr Obes Rep，2021，10（3）：244-262.
[10] Patrick DM，Sbihi H，Dai DLY，et al. Decreasing antibiotic use，the gut microbiota，and asthma incidence in children：evidence from population-based and prospective cohort studies [J]. Lancet Respir Med，2020，8（11）：1094-1105.
[11] Mubanga M，Lundholm C，D’Onofrio BM，et al. Association of early life exposure to antibiotics with risk of atopic dermatitis in Sweden [J]. JAMA Netw Open，2021，4（4）：e215245.
[12] 占凯，程良斌.中医“毒”之浅析[J].湖北中医药大学学报，2017，19（1）：47-50.
[13] 杨瑞，刘胜.中医外科学对“毒”的认识[J].中华中医药杂志，2021，36（6）：3290-3293.
[14] 孔一卜，郭婷婷，郭磊，等.国医大师王烈热毒理论治疗小儿风热感冒经验[J].中华中医药杂志，2020，35（1）：173-175.
[15] 孙佳红，王烈，孙丽平.王烈运用清感方治疗小儿风热感冒[J].长春中医药大学学报，2019，35（1）：46-48.
[16] 柳金英，任莹璐，任卫全，等.从炎性反应角度探讨清热解毒法治疗心力衰竭的意义[J].中华中医药杂志，2017， 32（11）：4901-4905.
[17] 郭婷婷，孙丽平，王烈.国医大师王烈治未病思想在儿科肺系疾病中的应用[J].中国医药导报，2021，18（17）：134-136，145.
[18] Hardelid P，Dattani N，Cortina-Borja M，et al. Contribution of respiratory tract infections to child deaths：a data linkage study [J]. BMC Public Health，2014，14（1）：1-10.
[19] 吕沛宛，赵广森，周鸿飞，等.基于《黄帝内经》理论的“治未病”方法探析[J].中华中医药杂志，2021，36（12）：7383-7385.
[20] 孔一卜，徐炎，孙丽平.基于“夙根伏痰”益气固本方调节免疫失衡治疗哮喘的作用机制探讨及思考[J].吉林中医药，2019，39（10）：1261-1263，1267.
[21] 孙丽平，王延博，冯晓纯，等.益气固本胶囊对脾气虚哮喘小鼠血清INF-γ及IL-4的影响[J].中华中医药杂志，2015，30（11）：4068-4070.
[22] 丁利忠，王延博，孙丽平，等.益气固本胶囊调控肾阳虚哮喘小鼠血清IL-4/INF-γ的实验研究[J].时珍国医国药，2015，26（9）：2059-2060.
[23] 付燕来，杲春阳，宋昌梅，等.中药香囊辟瘟囊预防时疫应用分析[J].陕西中医药大学学报，2021，44（6）：11- 14.
[24] 曾治君，刘洋，袁卫建，等.中药香囊的研究及发展现状[J].中华中医药杂志，2020，35（7）：3560-3562.
[25] 王力宁，邓普元，张毅贤，等.壮药防病香囊对小儿反复呼吸道感染易感人群干预效果研究[J].中医儿科杂志，2017，13（6）：22-25. |
|
|
|
